lti-01
Generic: single chain urokinase plasminogen activator (scuPA)
lti-01: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Rein Therapeutics, Inc. (RNTX) | Phase 2 |
Get deeper analysis on lti-01
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis